NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rarity Bioscience

Rarity Bioscience

Private
UppsalaHealthcare & Life Scienceshttps://raritybioscience.com/

Last Round

VC Round

Jun 18, 2024

Total Funding Raised

$3.22M

Company Overview

Rarity Bioscience is a biotechnology company that provides ultra-sensitive multiplex assays for mutation detection in liquid biopsies for research and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

liquid biopsymolecular diagnosticsrolling circle amplificationRCAmutation detectionprecision oncologyrare variant detectioncancer diagnosticsgenomic assaybiotech research toolsliquid biopsy testingmolecular profilingcancer screeningRUOresearch use only

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rarity Bioscience Comps

Public and private peers based on sector, stage, and business model.

Rarity Bioscience comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rarity Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 18, 2024
SeedFeb 6, 2023
AngelJul 12, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Lei Chen

CTO, Co-Founder

Founding Team

Linus Bosaeus

Chief Executive Officer

Executive Team

Rarity Bioscience Investors

Notable investors and investment history

Rarity Bioscience investors
InvestorRounds
Navigare VenturesSeed, VC Round
Uppsala University InvestAngel, VC Round, Seed
Novalis BiotechSeed, VC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 6, 2023

    $3.2M round led by Uppsala University Invest.

  • Jul 12, 2021

    Raised an Angel round with Uppsala University Invest.

View all signals

Rarity Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rarity Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rarity Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersUppsala
Employee Range27
Year Founded2021
Last FundingJun 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.